Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

HPV-6-targeting immunotherapeutic vaccine INO-3106

A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and antineoplastic activities. Administered via intramuscular electroporation, HPV-6-targeting immunotherapeutic vaccine INO-3106 expresses the HPV-6 E6 and E7 proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells that are expressing those proteins, resulting in tumor cell lysis. HPV-6 infections are associated with aerodigestive malignancies.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:HPV-6 E6/E7 DNA vaccine INO-3106
HPV-6-targeting immunotherapeutic INO-3106
Code name:INO-3106
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search